共 50 条
- [21] Preparation of carbon-14 labeled N-(2-ethyl-3-chloro-4-pyridinyl)-4-(4-chlorophenoxy)phenylacetamide JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1998, 41 (02): : 151 - 157
- [22] Effects of RGH-237 [N-{4-[4-(3-aminocarbonyl-phenyl)-piperazin-1-yl]-butyl}-4-bromo-benzamide], an orally active, selective dopamine D3 receptor partial agonist in animal models of cocaine abuse JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2007, 320 (03): : 1268 - 1278
- [28] PHARMACOLOGY OF N-[4-(4-MORPHOLINYLCARBONYL)BENZOYL]-L-VALYL-N-[3,3,4,4,4-PENTAFLUORO-1-(1-METHYLETHYL)-2-OXOBUTYL]-L-PROLINAMIDE (MDL-101,146) - A POTENT ORALLY-ACTIVE INHIBITOR OF HUMAN NEUTROPHIL ELASTASE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 270 (01): : 185 - 191
- [29] Neuropsychopharmacological characterization of a sulfonamide compound [4-(3-cyclopentyl-indole-1-sulfonyl)-N-(tetrahydropyran-4-ylmetryl)-benzamide], as a novel, potent, selective and orally active CB1 cannabinoid receptor antagonist INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S208 - S208